Study to quantify the benefits of adaptive radiotherapy in PET-CT based radiotherapy planning on patients of lung cancer
Not Applicable
Completed
- Conditions
- Health Condition 1: C348- Malignant neoplasm of overlappingsites of bronchus and lung
- Registration Number
- CTRI/2018/10/016171
- Lead Sponsor
- Dr Namrata Das
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Pathologically confirmed non small cell lung cancer
Stage III confirmed by FDG PET-CT
ECOG performance status 0 or 1
Exclusion Criteria
Other neoplasm in the last 5 years
Uncontrolled comorbidities like DM, HTN, TB
Pregnant or breastfeeding mother
Contradictions for cisplatin
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method